Travel Medicine Update

Icahn School of Medicine at Mount Sinai

D. Caplivski

Project 2025 vs. the Public's Health Part II: The FDA

MicrobeTV

P. Offit, V. Racaniello

Walking Pneumonia, the Beginning of Influenza Season, and Does Antiv…

MicrobeTV

D. Griffin, V. Racaniello

Nirsevimab for RSV: A Breakthrough Product for Babies

MicrobeTV

P. Offit, V. Racaniello

Hydrocortisone Reduces Mortality by 48% in Severe Community-Acquired…

MedCram

R. Seheult

IDWeek 2024 Insights: To Mask or Not to Mask - Approaches to Source …

IDWeek 2024 Insights

E. Landon

What to Know About the FDA Authorization and Approval of Updated COV…

Amesh Adalja

The Very Real Threat to Patient Access: Ongoing Medicare Physician C…

Corey Howard

L. Bucshon, S. Ransone, C. Yag-Howard, T. Cronin

COVID 2024 Surge: The Most Accessible Defense

MedCram

R. Seheult

Preparing for Winter: CDC Recommendations for Influenza, COVID-19, a…

Diego Hijano

The Durability of the Antibody Response Following Monkeypox Vaccinat…

MicrobeTV

D. Griffin, V. Racaniello

CHEST 2024 Insights: Vaccination Challenges and Strategies for Viral…

CHEST Annual Meeting Insights

A. Kapoor

What's New with COVID in 2024?

Michigan Medicine

L. Washer

EADV 2023 Insights: Non-Melanoma Skin Cancer Management in Organ Tra…

EADV 2023 Insights

G. Hofbauer

ACAAI 2024 Insights: Secondary Immunodeficiency - Management Strateg…

ACAAI 2024 Insights

S. Mustafa

Newly Licensed Respiratory Syncytial Virus Vaccines for Adults: What…

MicrobeTV

P. Offit, V. Racaniello

CHEST Insights 2024: Determining the Impact of COVID-19 Infection on…

CHEST Annual Meeting Insights

A. Arumairaj

Preventing Complications with Vaccines in Persons with Diabetes (PWD)

Allison Presnell

IDSA Guidelines for Using Anti-SARS-CoV-2 Monoclonal Antibody Therap…

MicrobeTV

D. Griffin, V. Racaniello

Emergency Use Authorization for Updated COVID Vaccine, West Nile Vir…

MicrobeTV

D. Griffin, V. Racaniello